SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic Fibrosis
Public ClinicalTrials.gov record NCT02279498. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Open-Label, Assessor-Blind, Noninferiority, Active-Comparator Study Evaluating the Efficacy and Safety of Liprotamase in Subjects With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
Study identification
- NCT ID
- NCT02279498
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Anthera Pharmaceuticals
- Industry
- Enrollment
- 128 participants
Conditions and interventions
Conditions
Interventions
- Liprotamase Drug
- porcine (pig) PERT Drug
Drug
Eligibility (public fields only)
- Age range
- 7 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2015
- Primary completion
- Sep 30, 2016
- Completion
- Jan 19, 2017
- Last update posted
- Aug 13, 2018
2015 – 2017
United States locations
- U.S. sites
- 32
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigator Site 123 | Long Beach | California | 90806 | — |
| Investigator Site 107 | Los Angeles | California | 90033 | — |
| Investigator Site 114 | Aurora | Colorado | 80045 | — |
| Investigator Site 120 | Gainesville | Florida | 32610 | — |
| Investigator Site 102 | Jacksonville | Florida | 32207 | — |
| Investigator Site 130 | Miami | Florida | 33136 | — |
| Investigator Site 117 | Orlando | Florida | 32803 | — |
| Investigator Site 110 | Atlanta | Georgia | 30342 | — |
| Investigator Site 127 | Chicago | Illinois | 60611 | — |
| Investigator Site 109 | Glenview | Illinois | 60025 | — |
| Investigator Site 104 | Indianapolis | Indiana | 46202 | — |
| Investigator Site 105 | Wichita | Kansas | 67214 | — |
| Investigator Site 128 | Lexington | Kentucky | 40506 | — |
| Investigator Site 122 | Louisville | Kentucky | 40202 | — |
| Investigator Site 132 | Portland | Maine | 04102 | — |
| Investigator Site 124 | Ann Arbor | Michigan | 48109-5212 | — |
| Investigator Site 126 | East Lansing | Michigan | 48823 | — |
| Investigator Site 134 | Jackson | Mississippi | 39216 | — |
| Investigator Site 135 | Las Vegas | Nevada | 89107 | — |
| Investigator Site 103 | Cleveland | Ohio | 44106 | — |
| Investigator Site 113 | Toledo | Ohio | 43606 | — |
| Investigator Site 101 | Oklahoma City | Oklahoma | 73104 | — |
| Investigator Site 136 | Oklahoma City | Oklahoma | 73112 | — |
| Investigator Site 119 | Portland | Oregon | 97239 | — |
| Investigator Site 106 | Hershey | Pennsylvania | 17033 | — |
| Investigator Site 115 | Pittsburgh | Pennsylvania | 15224 | — |
| Investigator Site 111 | Dallas | Texas | 75390 | — |
| Investigator Site 125 | Fort Worth | Texas | 76104 | — |
| Investigator Site 116 | Houston | Texas | 77030 | — |
| Investigator Site 121 | Burlington | Vermont | 05405 | — |
| Investigator Site 112 | Richmond | Virginia | 23219 | — |
| Investigator Site 129 | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02279498, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 13, 2018 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02279498 live on ClinicalTrials.gov.